1-methyl-3-isobutylxanthine has been researched along with Polyuria in 2 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Polyuria: Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "One of the mechanisms by which Li evokes polyuria is thought to be impairment of arginine vasopressin (AVP)-sensitive adenylate cyclase (AdC) in cells of the renal collecting duct." | 7.68 | Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats. ( Asano, Y; Homma, S; Kusano, E; Murayama, N; Takeda, S; Tetsuka, T; Yamaki, M, 1991) |
| "The involvement of prostaglandin E2 (PGE2), adenosine 3',5'-cyclic monophosphate (cAMP), and vasopressin in lithium-induced polyuria was investigated in rats." | 7.67 | Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria. ( Hashimoto, K; Ota, Z; Sugawara, M, 1988) |
| "One of the mechanisms by which Li evokes polyuria is thought to be impairment of arginine vasopressin (AVP)-sensitive adenylate cyclase (AdC) in cells of the renal collecting duct." | 3.68 | Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats. ( Asano, Y; Homma, S; Kusano, E; Murayama, N; Takeda, S; Tetsuka, T; Yamaki, M, 1991) |
| "The involvement of prostaglandin E2 (PGE2), adenosine 3',5'-cyclic monophosphate (cAMP), and vasopressin in lithium-induced polyuria was investigated in rats." | 3.67 | Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria. ( Hashimoto, K; Ota, Z; Sugawara, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaki, M | 1 |
| Kusano, E | 1 |
| Tetsuka, T | 1 |
| Takeda, S | 1 |
| Homma, S | 1 |
| Murayama, N | 1 |
| Asano, Y | 1 |
| Sugawara, M | 1 |
| Hashimoto, K | 1 |
| Ota, Z | 1 |
2 other studies available for 1-methyl-3-isobutylxanthine and Polyuria
| Article | Year |
|---|---|
Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats.
Topics: 1-Methyl-3-isobutylxanthine; Adenylate Cyclase Toxin; Animals; Arginine Vasopressin; Chlorides; Chol | 1991 |
Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arginine Vasopressin; Chlorides; Cyclic AMP; Dinoprostone; Kid | 1988 |